IKZF5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.116000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.900000E-01
Normal-vs-Stage2
5.052000E-02
Normal-vs-Stage3
2.043400E-01
Normal-vs-Stage4
7.561000E-01
Stage1-vs-Stage2
2.395000E-01
Stage1-vs-Stage3
6.666400E-02
Stage1-vs-Stage4
7.672400E-01
Stage2-vs-Stage3
1.498580E-01
Stage2-vs-Stage4
1.466800E-01
Stage3-vs-Stage4
1.701160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.761500E-02
Normal-vs-AfricanAmerican
5.616600E-01
Normal-vs-Asian
9.683600E-02
Caucasian-vs-AfricanAmerican
1.893780E-01
Caucasian-vs-Asian
5.166600E-01
AfricanAmerican-vs-Asian
1.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.384000E-02
Normal-vs-Female
1.165790E-01
Male-vs-Female
4.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.845400E-01
Normal-vs-Age(41-60Yrs)
1.959830E-01
Normal-vs-Age(61-80Yrs)
5.870400E-02
Normal-vs-Age(81-100Yrs)
2.737200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.644600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.556800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.328800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.218300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.844100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.948300E-02
Normal-vs-Daily Drinker
5.233500E-02
Normal-vs-Weekly Drinker
1.508970E-01
Normal-vs-Occasional Drinker
3.452000E-01
Normal-vs-Social Drinker
1.768170E-01
Non Drinker-vs-Daily Drinker
9.639400E-01
Non Drinker-vs-Weekly Drinker
7.491200E-01
Non Drinker-vs-Occasional Drinker
1.089770E-01
Non Drinker-vs-Social Drinker
5.302400E-01
Daily Drinker-vs-Weekly Drinker
7.531800E-01
Daily Drinker-vs-Occasional Drinker
1.488970E-01
Daily Drinker-vs-Social Drinker
5.575800E-01
Weekly Drinker-vs-Occasional Drinker
3.597600E-01
Weekly Drinker-vs-Social Drinker
8.292600E-01
Occasional Drinker-vs-Social Drinker
4.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.397500E-02
Normal-vs-Grade 2
1.140340E-02
Normal-vs-Grade 3
1.877600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.823600E-01
Grade 1-vs-Grade 3
7.630600E-01
Grade 1-vs-Grade 4
9.397500E-02
Grade 2-vs-Grade 3
6.302800E-01
Grade 2-vs-Grade 4
1.140340E-02
Grade 3-vs-Grade 4
1.877600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.796100E-02
Normal-vs-NonDiabetic
4.684300E-02
Diabetic-vs-NonDiabetic
7.634000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.626800E-01
Normal-vs-NoPancreatitis
5.941900E-02
Pancreatitis-vs-NoPancreatitis
4.982500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.551840E-01
Normal-vs-N1
5.128100E-02
N0-vs-N1
7.858000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.483200E-01
Normal-vs-TP53-NonMutant
3.624600E-01
TP53-Mutant-vs-TP53-NonMutant
2.120600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
